Related Experiment Videos
The Biotechnology Facility for International Space Station
Thomas Goodwin1, Charles Lundquist, Jennifer Tuxhorn
1NASA Johnson Space Center, Biological Systems Office, Houston, TX 77058, USA. thomas.j.goodwin@nasa.gov
Journal of Gravitational Physiology : a Journal of the International Society for Gravitational Physiology
|September 9, 2005
Summary
Microgravity research on the International Space Station (ISS) will advance cell biology and tissue engineering. The Biotechnology Facility (BTF) enables long-duration experiments, increasing scientific discoveries in space.
Area of Science:
- Cellular biotechnology
- Space biology
- Microgravity research
Background:
- The Cellular Biotechnology Program aims to leverage microgravity for biological studies.
- Microgravity offers unique conditions for fundamental cell biology and applied research like tissue engineering.
Purpose of the Study:
- To establish a state-of-the-art Biotechnology Facility (BTF) on the International Space Station (ISS).
- To advance cellular biotechnology research in the microgravity environment.
Main Methods:
- Utilizing the International Space Station (ISS) as a platform for microgravity research.
- Implementing continuous operation capabilities within the Biotechnology Facility (BTF).
Main Results:
- The BTF will provide advanced capabilities for cellular biotechnology.
- Continuous operation will facilitate long-duration experiments.
- On-orbit science throughput will be significantly increased.
Conclusions:
- The BTF on the ISS is crucial for advancing microgravity-based cell biology.
- This facility will enhance our understanding of fundamental biological principles.
- It will accelerate applications such as tissue engineering in space.